Tenax Therapeutics (TENX) Ending Cash Balance (2009 - 2026)
Tenax Therapeutics (TENX) reported Ending Cash Balance of $13.39 million for Q2 2023, up 85.3% from $7.23 million a year earlier but down 7.1% from the prior quarter.
Powered by 
Analysis
Tenax Therapeutics (TENX) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2022, Tenax Therapeutics posted Ending Cash Balance of $2.12 million, down 62.0% from FY2021.
- Ending Cash Balance has a three-year compound annual growth rate of -24.4% (FY2019 to FY2022).
- By year, Ending Cash Balance came in at $5.58 million in FY2021 (-10.7%), $6.25 million in FY2020 (+27.4%) and $4.91 million in FY2019.
- Five-year quarterly Ending Cash Balance spans a low of $2.12 million in Q4 2022 and a high of $14.41 million in Q1 2023.
- Year over year, Ending Cash Balance gained in two of the last five quarters, with growth averaging 72.1%.
- Per Business Quant data, the three quarters before Q2 2023 came in at $14.41 million (Q1 2023), $2.12 million (Q4 2022) and $3.81 million (Q3 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Tenax Therapeutics | 76.96 Mn | -371.07 Mn | - | 97.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 97.57 Mn |
| Jun 30, 2026 | 97.57 Mn |
| Mar 31, 2026 | 97.57 Mn |
| Dec 31, 2025 | 94.85 Mn |
| Sep 30, 2025 | 94.85 Mn |
| Jun 30, 2025 | 94.85 Mn |
| Mar 31, 2025 | 94.85 Mn |
| Dec 31, 2024 | 9.79 Mn |
| Sep 30, 2024 | 9.79 Mn |
| Jun 30, 2024 | 9.79 Mn |
| Mar 31, 2024 | 9.79 Mn |
| Dec 31, 2023 | 2.12 Mn |
| Sep 30, 2023 | 2.12 Bn |
| Jun 30, 2023 | 13.39 Mn |
| Mar 31, 2023 | 14.41 Mn |
| Dec 31, 2022 | 2.12 Mn |
| Sep 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 7.23 Mn |
| Mar 31, 2022 | 2.87 Mn |
| Dec 31, 2021 | 5.58 Mn |
API Access
Tenax Therapeutics Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=TENX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "TENX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=TENX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();